Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian’s perspective

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 18 July 2020]

 

Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian’s perspective
Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indica…
Authors: A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel and C. J. J. Mulder
Citation: Journal of Pharmaceutical Policy and Practice 2020 13:45
Content type: Review
Published on: 17 July 2020